XML 31 R73.htm IDEA: XBRL DOCUMENT v2.4.0.8
Quarterly Financial Data (Unaudited) (Details) (USD $)
In Millions, except Per Share data, unless otherwise specified
 3 Months Ended 12 Months Ended
Mar. 31, 2014
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2012
Selected quarterly financial information [Abstract]                      
Net sales $ 390.6 $ 347.0 $ 364.2 $ 375.8 $ 359.6 $ 326.1 $ 339.9 $ 350.4 $ 1,477.6 $ 1,376.0 $ 1,577.2
Gross profit 62.3 56.8 57.2 61.9 56.1 48.2 52.6 51.7 238.2 208.6 256.6
Earnings (loss) from continuing operations 119.7 [1],[2] (3.4) [1],[2] 5.0 [1],[2] 10.6 [1],[2] (1.6) [1] (8.4) [1] (11.8) [1] (1.0) [1] 131.9 (22.8) 38.0
Net earnings (loss) attributable to Modine 119.4 [1],[2] (3.6) [1],[2] 4.6 [1],[2] 10.0 [1],[2] (2.1) [1] (8.7) [1] (12.2) [1] (1.2) [1] 130.4 (24.2) 38.5
Net earnings (loss) per share attributable to Modine shareholders [Abstract]                      
Basic (in dollars per share) $ 2.51 [2] $ (0.08) $ 0.10 $ 0.21 $ (0.04) $ (0.19) $ (0.26) $ (0.03) $ 2.75 $ (0.52) $ 0.83
Diluted (in dollars per share) $ 2.49 [2] $ (0.08) $ 0.10 $ 0.21 $ (0.04) $ (0.19) $ (0.26) $ (0.03) $ 2.72 $ (0.52) $ 0.82
Deferred tax asset, valuation allowance 119.2               119.2    
Restructuring Charges 5.6 9.4 0.6 0.5 9.7 1.4 1.3 4.6 16.1 17.0 0
Impairment Charges $ 1.2 $ 2.0     $ 0.9 $ 8.3 $ 16.7   $ 3.2 $ 25.9 $ 2.5
[1] The quarterly financial data presented above includes restructuring expenses and impairment charges, primarily related to our Europe restructuring program and certain restructuring actions in the U.S. During fiscal 2014, restructuring expenses totaled $0.5 million, $0.6 million, $9.4 million, and $5.6 million for the quarters ended June 30, 2013, September 30, 2013, December 31, 2013, and March 31, 2014, respectively. The Company recorded impairment charges of $2.0 million and $1.2 million during the quarters ended December 31, 2013 and March 31, 2014, respectively. During fiscal 2013, restructuring expenses totaled $4.6 million, $1.3 million, $1.4 million, and $9.7 million for the quarters ended June 30, 2012, September 30, 2012, December 31, 2012, and March 31, 2013, respectively. The Company recorded impairment charges of $16.7 million, $8.3 million, and $0.9 million during the quarters ended September 30, 2012, December 31, 2012, and March 31, 2013, respectively. See Note 6 for additional information.
[2] The quarter ended March 31, 2014 was benefited by the reversal of U.S. income tax valuation allowances totaling $119.2 million. See Note 8 for additional information.